Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study (2020)
- Authors:
- USP affiliated authors: SANTOS FILHO, RAUL DIAS DOS - FM ; LOTUFO, PAULO ANDRADE - FM ; BENSEÑOR, ISABELA JUDITH MARTINS - FM
- Unidade: FM
- DOI: 10.1016/j.atherosclerosis.2020.08.021
- Subjects: COLESTEROL; HIPERTIREOIDISMO; DIAGNÓSTICO; EPIDEMIOLOGIA; MEIA IDADE
- Agências de fomento:
- Brazilian Ministry of Science and Technology (CNPq National Research Council) [01 06 0010.00 RS, 01 06 0212.00BA, 01 06 0300.00 ES, 01 06 0278.00MG, 01 06 0115.00 SP, 01 06 0071.00 RJ]
- Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos) [01 06 0010.00 RS, 01 06 0212.00BA, 01 06 0300.00 ES, 01 06 0278.00MG, 01 06 0115.00 SP, 01 06 0071.00 RJ]
- Brazilian Ministry of Health (Science and Technology Department)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Atherosclerosis
- ISSN: 0021-9150
- Volume/Número/Paginação/Ano: v. 312, p. 60-65, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
JANOVSKY, Carolina Castro Porto Silva et al. Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study. Atherosclerosis, v. 312, p. 60-65, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2020.08.021. Acesso em: 19 set. 2024. -
APA
Janovsky, C. C. P. S., Generoso, G., Goulart, A. C., Santos Filho, R. D. dos, Blaha, M. J., Jones, S., et al. (2020). Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study. Atherosclerosis, 312, 60-65. doi:10.1016/j.atherosclerosis.2020.08.021 -
NLM
Janovsky CCPS, Generoso G, Goulart AC, Santos Filho RD dos, Blaha MJ, Jones S, Toth PP, Lotufo PA, Bittencourt MS, Benseñor IJM. Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study [Internet]. Atherosclerosis. 2020 ; 312 60-65.[citado 2024 set. 19 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.021 -
Vancouver
Janovsky CCPS, Generoso G, Goulart AC, Santos Filho RD dos, Blaha MJ, Jones S, Toth PP, Lotufo PA, Bittencourt MS, Benseñor IJM. Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study [Internet]. Atherosclerosis. 2020 ; 312 60-65.[citado 2024 set. 19 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.021 - Prevalência de Diagnóstico Médico de Colesterol Alto Autorreferido na População Brasileira: Análise da Pesquisa Nacional de Saúde, 2013
- Prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in Brazil: baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-BRASIL)
- Association Between Triglycerides, High-Density Lipoprotein Cholesterol, and Their Ratio With the Pulse Wave Velocity in Adults From the ELSA-Brasil Study
- GlycA as a Novel Biomarker of Systemic Inflammation in Hypothyroidism
- Familial hypercholesterolemia prevalence in an admixed racial society: sex and race matter. The ELSA-Brasil
- The association between triglyceride-rich lipoproteins, circulating leukocytes, and low-grade inflammation: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
- Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement
- Substantially elevated TSH, not traditional clinical subclinical thyroid disorder groupings, are associated with smaller LDL-P mean size: ELSA-Brasil
- Sintomas depressivos persistentes são preditores independentes de início de inflamação de baixo grau em indivíduos saudáveis
- Percentiles of predicted 10-year cardiovascular disease risk by sex and age in Brazil and their association with estimated risk of long-term atherosclerotic events
Informações sobre o DOI: 10.1016/j.atherosclerosis.2020.08.021 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
